← Back to Search

Herbal Supplement

Gingko Biloba for Healthy Subjects

N/A
Waitlist Available
Research Sponsored by State University of New York College of Optometry
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 weeks
Awards & highlights

Study Summary

This trial will help researchers understand if taking Ginkgo Biloba orally can help improve vision by looking at changes in the retina and choroid.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
ocular blood flow

Side effects data

From 2011 Phase 4 trial • 47 Patients • NCT00103012
6%
dysmenorrhea
6%
diarrhea
6%
electrolyte imbalance
6%
common cold
100%
80%
60%
40%
20%
0%
Study treatment Arm
Influence of Ginkgo Biloba on Lopinavir/Ritonavir Disposition
Influence of Echinacea on Lopinavir/Ritonavir Disposition
Influence of Panax Ginseng on Lopinavir/Ritonavir Disposition

Trial Design

1Treatment groups
Experimental Treatment
Group I: Gingko BilobaExperimental Treatment1 Intervention
oral intake of gingko biloba for 4 weeks
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Gingko Biloba
2021
Completed Phase 4
~130

Find a Location

Who is running the clinical trial?

State University of New York College of OptometryLead Sponsor
19 Previous Clinical Trials
1,116 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
New Jersey
New York
How old are they?
18 - 65
What site did they apply to?
SUNY College of Optometry
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
~5 spots leftby Apr 2025